Who owns PharmaCyte Biotech, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PMCB from SEC Form 13F filings across 29 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 29 institutions disclosed 762,760 shares of PharmaCyte Biotech, Inc. worth $586,231 — about 7.1% of shares outstanding; the largest disclosed holder is CITADEL ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
29
13F holders
$586,231
value, 2026 filers
7.1%
of shares outstanding (762,760 sh)
4
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PMCB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 283,381 | $218,203 | 0.0% | 2.6% | -21.2% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 124,247 | $95,681 | 0.0% | 1.2% | -36.5% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 56,778 | $43,719 | 0.0% | 0.5% | +10.3% |
| 4 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 44,853 | $34,536 | 0.0% | 0.4% | new |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 37,987 | $29,250 | 0.0% | 0.4% | -32.8% |
| 6 | XTX Topco Ltd | 34,180 | $26,319 | 0.0% | 0.3% | -34.7% |
| 7 | NORTHERN TRUST CORP | 32,624 | $25,120 | 0.0% | 0.3% | -8.4% |
| 8 | JANE STREET GROUP, LLC | 30,064 | $23,149 | 0.0% | 0.3% | +160.7% |
| 9 | Schonfeld Strategic Advisors LLC | 26,926 | $20,733 | 0.0% | 0.3% | -0.3% |
| 10 | VANGUARD FIDUCIARY TRUST CO | 23,452 | $18,058 | 0.0% | 0.2% | 0.0% |
| 11 | EQUITEC PROPRIETARY MARKETS, LLC | 22,227 | $17,115 | 0.0% | 0.2% | 0.0% |
| 12 | COMMONWEALTH EQUITY SERVICES, LLC | 20,255 | $15,600 | 0.0% | 0.2% | +96.4% |
| 13 | HRT FINANCIAL LP | 15,451 | $11,000 | 0.0% | 0.1% | -37.5% |
| 14 | Tower Research Capital LLC (TRC) | 4,888 | $3,764 | 0.0% | 0% | 0.0% |
| 15 | UBS Group AG | 4,142 | $3,189 | 0.0% | 0% | -8.3% |
| 16 | GROUP ONE TRADING LLC | 500 | $385 | 0.0% | 0% | -72.0% |
| 17 | OSAIC HOLDINGS, INC. | 303 | $232 | 0.0% | 0% | +0.3% |
| 18 | Covestor Ltd | 275 | $0 | 0.0% | 0% | 0.0% |
| 19 | BARCLAYS PLCNEW | 192 | $148 | 0.0% | 0% | new |
| 20 | Sachetta, LLC | 14 | $11 | 0.0% | 0% | 0.0% |
| 21 | SBI Securities Co., Ltd. | 6 | $5 | 0.0% | 0% | +100.0% |
| 22 | BFSG, LLC | 5 | $4 | 0.0% | 0% | 0.0% |
| 23 | FINANCIAL CONSULATE, INC | 2 | $2 | 0.0% | 0% | 0.0% |
| 24 | NewEdge Advisors, LLCNEW | 2 | $2 | 0.0% | 0% | new |
| 25 | MORGAN STANLEY | 2 | $2 | 0.0% | 0% | +100.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.